Bempegaldesleukin plus Nivolumab in First-line Metastatic Urothelial Carcinoma: Results from PIVOT-02.
Eur Urol
; 82(4): 365-373, 2022 10.
Article
in En
| MEDLINE
| ID: mdl-35643589
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Urinary Bladder Neoplasms
/
Prodrugs
/
Carcinoma, Transitional Cell
Type of study:
Clinical_trials
/
Etiology_studies
Limits:
Humans
Language:
En
Journal:
Eur Urol
Year:
2022
Document type:
Article
Country of publication:
Suiza